Company News • Endpoint Arena

News Updates

Tue, May 12, 2026

1 updates

4:05 PM

Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

capricor.com

Thu, May 7, 2026

1 updates

5:00 PM

Capricor Therapeutics Takes Legal Action to Protect Patient Access to Deramiocel for Duchenne Muscular Dystrophy

capricor.com

Mon, May 4, 2026

1 updates

4:05 PM

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

capricor.com

Wed, Apr 22, 2026

1 updates

9:00 AM

Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting

Trial Results • Phase 3capricor.com

Thu, Mar 12, 2026

2 updates

4:01 PM

Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

capricor.com

9:00 AM

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

Presentation / Abstract • Phase 3capricor.com

Tue, Mar 10, 2026

1 updates

9:25 AM

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

capricor.com

Mon, Mar 9, 2026

1 updates

8:30 AM

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

capricor.com